首页> 外国专利> SIGMA-1 AGONIST OF AFOBAZOL RECEPTORS-A NEW MEDICINAL PREVENTION FOR PREVENTION OF EXCEPTIONAL CARDIAC MORTALITY IN PATIENTS AFFECTING ALCOHOLIC CARDIOMYOPATHY AND METHOD OF ITS MODEL

SIGMA-1 AGONIST OF AFOBAZOL RECEPTORS-A NEW MEDICINAL PREVENTION FOR PREVENTION OF EXCEPTIONAL CARDIAC MORTALITY IN PATIENTS AFFECTING ALCOHOLIC CARDIOMYOPATHY AND METHOD OF ITS MODEL

机译:阿法巴唑受体的SIGMA-1激动剂-一种预防酒精性心肌病的患者异常心脏死亡率的新药物预防方法及其模型

摘要

1. The use of 5-ethoxy-2- [2- (morpholino) -ethylthio] benzimidazole dihydrochloride - afobazole - as a means for the prevention of sudden cardiac death in alcoholic cardiomyopathy. 2. A method for modeling alcoholic cardiomyopathy, which consists in forced alcoholization of animals with a 10% aqueous solution of ethanol for 13 weeks, the subsequent selection of animals with a high preference for alcohol and continued alcoholization until the end of 6 months from the start of alcoholization.
机译:1.使用5-乙氧基-2- [2-(吗啉代)-乙硫基]苯并咪唑二盐酸盐-阿法巴唑作为预防酒精性心肌病猝死的方法。 2.一种对酒精性心肌病进行建模的方法,该方法包括用10%的乙醇水溶液对动物进行强制性酒精化13周,随后选择对酒精有高度偏爱的动物,并继续进行酒精化,直到自该日起6个月结束。开始酗酒。

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号